260 related articles for article (PubMed ID: 21083052)
1. Microdosing: a valuable tool for accelerating drug development and the role of bioanalytical methods in meeting the challenge.
Ings RM
Bioanalysis; 2009 Oct; 1(7):1293-305. PubMed ID: 21083052
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of microdosing to assess pharmacokinetic linearity in rats using liquid chromatography-tandem mass spectrometry.
Balani SK; Nagaraja NV; Qian MG; Costa AO; Daniels JS; Yang H; Shimoga PR; Wu JT; Gan LS; Lee FW; Miwa GT
Drug Metab Dispos; 2006 Mar; 34(3):384-8. PubMed ID: 16326814
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of microdosing strategies for studies in preclinical drug development: demonstration of linear pharmacokinetics in dogs of a nucleoside analog over a 50-fold dose range.
Sandhu P; Vogel JS; Rose MJ; Ubick EA; Brunner JE; Wallace MA; Adelsberger JK; Baker MP; Henderson PT; Pearson PG; Baillie TA
Drug Metab Dispos; 2004 Nov; 32(11):1254-9. PubMed ID: 15286054
[TBL] [Abstract][Full Text] [Related]
4. New ultrasensitive detection technologies and techniques for use in microdosing studies.
Lappin G; Wagner CC; Langer O; van de Merbel N
Bioanalysis; 2009 May; 1(2):357-66. PubMed ID: 21083172
[TBL] [Abstract][Full Text] [Related]
5. Practical experience of using human microdosing with AMS analysis to obtain early human drug metabolism and PK data.
Garner RC
Bioanalysis; 2010 Mar; 2(3):429-40. PubMed ID: 21083253
[TBL] [Abstract][Full Text] [Related]
6. Microdosing studies using accelerated mass spectrometry as exploratory investigational new drug trials.
Bae SK; Shon JH
Arch Pharm Res; 2011 Nov; 34(11):1789-98. PubMed ID: 22139681
[TBL] [Abstract][Full Text] [Related]
7. Accelerator MS: its role as a frontline bioanalytical technique.
Seymour MA
Bioanalysis; 2011 Dec; 3(24):2817-23. PubMed ID: 22185281
[TBL] [Abstract][Full Text] [Related]
8. Recent development in high-throughput bioanalytical support for in vitro ADMET profiling.
Shou WZ; Zhang J
Expert Opin Drug Metab Toxicol; 2010 Mar; 6(3):321-36. PubMed ID: 20163321
[TBL] [Abstract][Full Text] [Related]
9. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
[TBL] [Abstract][Full Text] [Related]
10. Novel strategies for microdose studies using non-radiolabeled compounds.
Maeda K; Sugiyama Y
Adv Drug Deliv Rev; 2011 Jun; 63(7):532-8. PubMed ID: 21345359
[TBL] [Abstract][Full Text] [Related]
11. Analytical strategies for identifying drug metabolites.
Prakash C; Shaffer CL; Nedderman A
Mass Spectrom Rev; 2007; 26(3):340-69. PubMed ID: 17405144
[TBL] [Abstract][Full Text] [Related]
12. Big physics, small doses: the use of AMS and PET in human microdosing of development drugs.
Lappin G; Garner RC
Nat Rev Drug Discov; 2003 Mar; 2(3):233-40. PubMed ID: 12612650
[TBL] [Abstract][Full Text] [Related]
13. Recent advances in high-throughput quantitative bioanalysis by LC-MS/MS.
Xu RN; Fan L; Rieser MJ; El-Shourbagy TA
J Pharm Biomed Anal; 2007 Jun; 44(2):342-55. PubMed ID: 17360141
[TBL] [Abstract][Full Text] [Related]
14. Microdose study of a P-glycoprotein substrate, fexofenadine, using a non-radioisotope-labelled drug and LC/MS/MS.
Yamazaki A; Kumagai Y; Yamane N; Tozuka Z; Sugiyama Y; Fujita T; Yokota S; Maeda M
J Clin Pharm Ther; 2010 Apr; 35(2):169-75. PubMed ID: 20456735
[TBL] [Abstract][Full Text] [Related]
15. Automatic mass spectrometry method development for drug discovery: application in metabolic stability assays.
Chovan LE; Black-Schaefer C; Dandliker PJ; Lau YY
Rapid Commun Mass Spectrom; 2004; 18(24):3105-12. PubMed ID: 15565734
[TBL] [Abstract][Full Text] [Related]
16. Accelerator mass spectrometry offers new opportunities for microdosing of peptide and protein pharmaceuticals.
Salehpour M; Ekblom J; Sabetsky V; Håkansson K; Possnert G
Rapid Commun Mass Spectrom; 2010 May; 24(10):1481-9. PubMed ID: 20411588
[TBL] [Abstract][Full Text] [Related]
17. Microfluidic chip-based liquid chromatography coupled to mass spectrometry for determination of small molecules in bioanalytical applications.
Lin SL; Bai HY; Lin TY; Fuh MR
Electrophoresis; 2012 Feb; 33(4):635-43. PubMed ID: 22451056
[TBL] [Abstract][Full Text] [Related]
18. Applicability of bioanalysis of multiple analytes in drug discovery and development: review of select case studies including assay development considerations.
Srinivas NR
Biomed Chromatogr; 2006 May; 20(5):383-414. PubMed ID: 16307470
[TBL] [Abstract][Full Text] [Related]
19. AMS method validation for quantitation in pharmacokinetic studies with concomitant extravascular and intravenous administration.
Lappin G; Seymour M; Young G; Higton D; Hill HM
Bioanalysis; 2011 Feb; 3(4):393-405. PubMed ID: 21338259
[TBL] [Abstract][Full Text] [Related]
20. 'LC-electrolyte effects' improve the bioanalytical performance of liquid chromatography/tandem mass spectrometric assays in supporting pharmacokinetic study for drug discovery.
Wang L; Sun Y; Du F; Niu W; Lu T; Kan J; Xu F; Yuan K; Qin T; Liu C; Li C
Rapid Commun Mass Spectrom; 2007; 21(16):2573-84. PubMed ID: 17639570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
